Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Advances in Chronic Kidney Disease
|
January 25, 2017
Cognitive Bias and the Creation and Translation of Evidence Into Clinical Practice
Donald A Molony
ACP Journal Club
|
January 6, 2007
Review: rofecoxib increases renal events and arrhythmia, but a COX-2-inhibitor class effect does not exist
Donald A Molony
ACP Journal Club
|
December 17, 2008
Annual zoledronic acid did not increase renal abnormalities at 2 years in postmenopausal women with osteoporosis
Donald A Molony
Annals of Internal Medicine
|
December 21, 2011
ACP Journal Club. Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD
Donald A Molony
Advances in Chronic Kidney Disease
|
March 4, 2018
Measurement of Glomerular Filtration Rate as a Diagnostic Test: Old Limitations and New Directions and Challenges Worthy of an Olympic Gold Medal
Donald A Molony, Jerry Yee
Annals of Internal Medicine
|
January 1, 2024
In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels
Daniel Rospert, Donald A Molony
Advances in Chronic Kidney Disease
|
January 25, 2017
Translation of Evidence Into Clinical Practice
Donald A Molony, Joshua Samuels
Blood Purification
|
April 16, 2005
Accumulation of metals and minerals from phosphate binders
Donald A Molony, Bhamidipati Murthy
Annals of Internal Medicine
|
September 4, 2023
In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories
Ali Ziaolhagh, Donald A Molony
Advances in Chronic Kidney Disease
|
March 17, 2011
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations
Donald A Molony, Brett W Stephens
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Advances in Chronic Kidney Disease
|
January 25, 2017
Cognitive Bias and the Creation and Translation of Evidence Into Clinical Practice
Donald A Molony
ACP Journal Club
|
January 6, 2007
Review: rofecoxib increases renal events and arrhythmia, but a COX-2-inhibitor class effect does not exist
Donald A Molony
ACP Journal Club
|
December 17, 2008
Annual zoledronic acid did not increase renal abnormalities at 2 years in postmenopausal women with osteoporosis
Donald A Molony
Annals of Internal Medicine
|
December 21, 2011
ACP Journal Club. Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD
Donald A Molony
Advances in Chronic Kidney Disease
|
March 4, 2018
Measurement of Glomerular Filtration Rate as a Diagnostic Test: Old Limitations and New Directions and Challenges Worthy of an Olympic Gold Medal
Donald A Molony, Jerry Yee
Annals of Internal Medicine
|
January 1, 2024
In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels
Daniel Rospert, Donald A Molony
Advances in Chronic Kidney Disease
|
January 25, 2017
Translation of Evidence Into Clinical Practice
Donald A Molony, Joshua Samuels
Blood Purification
|
April 16, 2005
Accumulation of metals and minerals from phosphate binders
Donald A Molony, Bhamidipati Murthy
Annals of Internal Medicine
|
September 4, 2023
In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories
Ali Ziaolhagh, Donald A Molony
Advances in Chronic Kidney Disease
|
March 17, 2011
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations
Donald A Molony, Brett W Stephens
Page
of 5